ARCHIVES

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer

December 11, 1998

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991